Analysis depression
Analysis suppression can be described as a distinct decrease in one's overall ability to process information and logically or creatively analyze concepts, ideas, and scenarios. The experience of this leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.
Analysis suppression will often synergize with other coinciding effects such as thought deceleration and emotion suppression in a manner which further decreases one's cognitive abilities. It is most commonly induced under the influence of moderate dosages of antipsychotics. However, it can also occur less consistently under the influence of very heavy dosages of dissociatives, cannabinoids, and GABAergics.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1,4-Butanediol
- 2M2B
- 3-MeO-PCE
- 3-MeO-PCMo
- 4-MeO-PCP
- 5F-AKB48
- 5F-PB-22
- AB-FUBINACA
- APICA
- Alcohol
- Alprazolam
- Amanita muscaria
- Baclofen
- Barbiturates
- Benzodiazepines
- Bromazepam
- Cannabis
- Carisoprodol
- Clonazepam
- Clonazolam
- DOB
- Deschloroetizolam
- Deschloroketamine
- Dextromethorphan
- Diazepam
- Diclazepam
- Diphenhydramine
- Diphenidine
- Ephenidine
- Eszopiclone
- Etizolam
- F-Phenibut
- Flualprazolam
- Flubromazepam
- Flubromazolam
- Flunitrazepam
- Flunitrazolam
- GBL
- GHB
- Gabapentin
- Gaboxadol
- HXE
- JWH-018
- JWH-073
- Ketamine
- Lorazepam
- Memantine
- Methaqualone
- Methoxetamine
- Methoxphenidine
See also
- Responsible use
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects